Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
SAFETY AND EFFICACY OF FILGOTINIB IN PATIENTS AGED 65 YEARS AND OLDER: RESULTS FROM A PHASE 3 STUDY IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) Kalunian, K., Gottenberg, J., Genovese, M. C., Mozaffarian, N., Bartok, B., Matzkies, F., Gao, J., Guo, Y., Takeuchi, T., de Vlam, K., Walker, D. BMJ PUBLISHING GROUP. 2019: 748–49
View details for DOI 10.1136/annrheumdis-2019-eular.2121
View details for Web of Science ID 000472207102197